NCT04735536View on ClinicalTrials.gov

Pilot Clinical Study of CT1812 in Mild to Moderate Alzheimer's Disease Using EEG

PHASE2CompletedINTERVENTIONAL
Enrollment

16

Participants

Timeline

Start Date

July 9, 2020

Primary Completion Date

April 26, 2023

Study Completion Date

April 26, 2023

Conditions
Alzheimer Disease
Interventions
DRUG

CT1812

Active Treatment- CT1812 at a dose of 300mg

OTHER

Placebo

Placebo Comparator

Trial Locations (1)

Unknown

Brain Research Center, Amsterdam

Sponsors
All Listed Sponsors
collaborator

National Institute on Aging (NIA)

NIH

lead

Cognition Therapeutics

INDUSTRY

NCT04735536 - Pilot Clinical Study of CT1812 in Mild to Moderate Alzheimer's Disease Using EEG | Biotech Hunter | Biotech Hunter